Warner Financial Inc. Lowers Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Warner Financial Inc. reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 21.1% in the fourth quarter, Holdings Channel reports. The fund owned 3,605 shares of the exchange traded fund’s stock after selling 965 shares during the quarter. Warner Financial Inc.’s holdings in SPDR S&P Biotech ETF were worth $325,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the business. Toronto Dominion Bank raised its position in SPDR S&P Biotech ETF by 16.3% during the 2nd quarter. Toronto Dominion Bank now owns 21,743 shares of the exchange traded fund’s stock valued at $2,016,000 after purchasing an additional 3,048 shares in the last quarter. Granite FO LLC purchased a new position in SPDR S&P Biotech ETF in the 2nd quarter worth $223,000. Invst LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth about $246,000. Perceptive Advisors LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 145.3% in the 2nd quarter. Perceptive Advisors LLC now owns 22,665 shares of the exchange traded fund’s stock valued at $2,101,000 after acquiring an additional 72,665 shares during the last quarter. Finally, B. Riley Wealth Advisors Inc. raised its stake in shares of SPDR S&P Biotech ETF by 144.0% during the 2nd quarter. B. Riley Wealth Advisors Inc. now owns 17,253 shares of the exchange traded fund’s stock valued at $1,600,000 after buying an additional 10,182 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $92.61 on Tuesday. The company’s fifty day moving average price is $93.35 and its 200 day moving average price is $96.87. The stock has a market capitalization of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.